4//SEC Filing
Grant Angus 4
Accession 0000950170-24-026019
CIK 0000818686other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:30 PM ET
Size
5.9 KB
Accession
0000950170-24-026019
Insider Transaction Report
Form 4
Grant Angus
EVP, Business Development
Transactions
- Award
Restricted Share Units
2024-03-04+52,083→ 52,083 total→ Ordinary Shares (52,083 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on March 4, 2024, with 13,020 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 13,023 vesting on March 4, 2028.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001988830
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:30 PM ET
- Size
- 5.9 KB